Gossamer Bio - GOSS Net Assets per Single Share

Graphic logo of Gossamer Bio, Inc. (GOSS)

The stock price trend for Gossamer Bio, Inc. (GOSS) reflects the asset's dynamics, with its current metric fixed at -15.29. The business focuses on developing advanced therapies for severe pulmonary and immune pathologies. However, development is complicated by global conflicts that hinder cross-border research and the supply of rare reagents. Despite past mistakes, the company's image is recovering through reliable alliances and moderate market optimism.

Gossamer Bio Inc (GOSS): Share Book Value from 07/04/2022 to 10/27/2026

gossamerbio.com - analytical breakdowns and key metrics (GOSS)

- price and consensus price forecast:
Price Chart Gossamer Corp|GOSS - Analyst Median Target
- market capitalization data:
Market Value Gossamer Bio, Inc.|GOSS - Company Buyout Price
- book capitalization data:
Net Assets per Single Share Gossamer Bio|GOSS - Net Asset Value|Market Capitalization to Book Value Ratio gossamerbio.com|GOSS - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital Gossamer Bio, Inc.|GOSS - Long-Term Debt to Capital|Short-Term Debt to Equity Gossamer Bio|GOSS - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Gossamer Bio, Inc.
Fundamental company valuation:Gossamer Corp - GOSS
Manufactured products of Gossamer Bio

Book value per share determines the portion of equity attributable to a single security after deducting all liabilities. This metric serves as an indicator of the actual protection of investments by the issuer's tangible assets. Analyzing the net asset value per share allows for an assessment of the company's fundamental resilience to market shocks. For Gossamer Bio, Inc. (GOSS), the reliability of the base is supported by a stable composition of top management and leading immunologists. Effective retention of intellectual capital through stock options minimizes the risks of intangible asset impairment.

Competitors of Gossamer Bio, Inc. (GOSS)

Net Assets per Single Share ARGX (Argenx)|BNTX: Net Assets per Share|Abivax Corp - Net Assets per Single Share|ADMA (admabiologics.com) - Net Assets per Share|Net Assets per Single Share Protagonist PTGX|Share Book Value Immunovant Inc|Kiniksa Pharmaceuticals Ltd (KNSA) - Book Value per Share|Accounting Value of a Share Grifols Biemat (GRFS)|Book Value per Share ADPT (Adaptive Biotechnologies)|celldex.com - Book Value per Share|Net Assets per Single Share Aurinia Pharmaceuticals Inc. (AUPH)|BCRX: Accounting Value of a Share|VERA (Vera Pharma) - Net Assets per Single Share|Dianthus Corp (DNTH) - Accounting Value per Share|PHVS (Pharvaris N.V.) - Book Value per Share|Book Value per Share AbCellera Corp (ABCL)|Tourmaline Bio (TRML) - Accounting Value per Share|Accounting Value of a Share Precigen Inc (PGEN)|Book Value per Share PHAR|Nektar Corp - Net Assets per Share|UPB: Net Assets per Single Share|ZBIO: Accounting Value per Share|IMNM (Immunome) - Net Assets per Single Share|Accounting Value per Share KalVista Pharma|SEPN (Septerna Corp) - Accounting Value per Share|Book Value per Share PVLA|Net Assets per Single Share Savara Inc. SVRA|Equity per Share rigel.com (RIGL)|ANAB: Book Value per Share|Net Asset Value per Share Astria Therapeutics Inc ATXS|Book Value per Share ENGN|RAPT: Book Value of One Share|Net Assets per Single Share JBIO|ACRS (aclaristx.com) - Net Asset Value per Share|KYTX: Net Assets per Single Share|Net Assets per Share TLSA|CABA (Cabaletta Bio, Inc) - Net Assets per Single Share|Net Assets per Share Ventyx Biosciences, Inc (VTYX)|Book Value per Share THTX (Theratechnologies Inc.)|avalotx.com - Book Value per Share|ELDN: Net Assets per Single Share|AGEN - Accounting Value per Share|Book Value per Share CLYM|ZURA (Zura Bio Ltd) - Net Asset Value per Share|ATYR - Net Assets per Single Share|Accounting Value of a Share Adagene Corp (ADAG)|ImageneBio Inc (IMA) - Accounting Value per Share|Accounting Value of a Share shattucklabs.com (STTK)|Book Value per Share Equillium EQ|Net Assets per Single Share Connect Biopharma Holdings CNTB|Book Value per Share IMUX (Immunic Inc)|ATRA: Net Assets per Share|Net Assets per Single Share IFRX|Net Asset Value per Share X4 Pharmaceuticals Inc.|ACET - Accounting Value per Share|Accounting Value of a Share Celularity Corp|INMB (INmune Bio, Inc.) - Book Value per Share|Net Assets per Share BRNS (barinthusbio.com)|KZR - Net Assets per Single Share|Equity per Share SAB Biotherapeutics Inc. SABS|AKTX: Book Value per Share|Enlivex Therapeutics (ENLV) - Accounting Value per Share|q32bio.com - Accounting Value per Share|geovax.com (GOVX) - Net Assets per Share|Edesa Biotech - Book Value per Share|Book Value of One Share IBIO|Carisma Therapeutics - Net Assets per Single Share|Net Asset Value per Share XTLB (XTL Bio)|Net Assets per Single Share BOLT|HCW Biologics, Inc. - Net Assets per Share|Net Assets per Single Share APVO (Aptevo)|AIM: Net Assets per Share|Net Assets per Single Share aditxt.com (ADTX)|GRI Bio Corporation (GRI) - Share Book Value|XRTX - Book Value per Share|Accounting Value of a Share reshapelifesciences.com|Book Value per Share REVB|Book Value per Share INDP (Indaptus Therapeutics Inc)|Net Assets per Single Share Scinai|CalciMedica Inc - Accounting Value of a Share|AFMD: Net Assets per Single Share|ALLK - Accounting Value per Share|HOOK: Book Value per Share|Book Value per Share IGM Biosciences|ITOS - Accounting Value per Share|Accounting Value of a Share Ocean Biomedical Corp|TCBP (TC Biopharm) - Book Value per Share|Net Assets per Share THRD (thirdharmonicbio.com)